ACP5 has been shown to correlate with poor patient prognosis in cancers such as gastric and rectal cancers, and to correlate with malignant tumor progression by affecting malignant phenotypes such as cell proliferation and invasion (Bian et al., 2019; An et al., 2021). Here, ACP5 is linked to cancer.